Literature DB >> 22442750

ApoE isoforms, treatment of diabetes and the risk of coronary heart disease.

Hideki Ehara1, Ritsuko Yamamoto-Honda, Hiroji Kitazato, Yoshihiko Takahashi, Shoji Kawazu, Yasuo Akanuma, Mitsuhiko Noda.   

Abstract

AIM: To analyze the risk of coronary heart disease in patients with type 2 diabetes mellitus (T2DM) receiving standard medical treatment.
METHODS: We performed a retrospective chart analysis of 269 middle-aged patients (age 45-64 years, mean age, 53.9 ± 5.5 years) with T2DM and without atherosclerotic cardiovascular events who underwent typing to determine their apolipoprotein E (apoE) isoforms. The apoE isoforms were determined using isoelectric focusing, followed by immunoblotting. We retrospectively evaluated the charts of the 269 patients, recorded between their first visit to the hospital (the study's start point, between 1987 and 1992) and the occurrence of an atherosclerotic cardiovascular event (the study's endpoint) or January 2004, whichever came first. The age-adjusted mean values and the prevalences of covariates were calculated to compare the laboratory data among the apoE phenotypes. To investigate the association of risk factors with the incidence of coronary heart disease during the follow-up period, monovariate and multivariate Cox regression models were used.
RESULTS: At enrollment, the mean serum low density lipoprotein (LDL) cholesterol levels were lowest (2.92 ± 0.89 mmol/L) among the subjects with apoE2 (apoE2/2 or apoE2/3) and highest (3.52 ± 0.77 mmol/L) among the subjects with apoE4 (apoE3/4 or apoE4/4). No significant differences in mean age or the percentage of smokers were observed among the three groups. Furthermore, no significant differences were observed in the systolic and diastolic blood pressures, body mass index, HbA1c level or serum triglyceride levels among the three groups. There were 47 cases of coronary heart disease over 3285 person-years of follow-up. An age-adjusted multivariate Cox proportional model identified diabetic retinopathy (hazard ratio, 2.38, 95% CI: 1.28-4.43, P = 0.006), a high systolic blood pressure (hazard ratio, 1.04, 95% CI: 1.02-1.06, P < 0.001) and high HbA1c values (hazard ratio, 1.19, 95% CI: 1.02-1.38, P = 0.0029), but not the LDL cholesterol value at enrollment (hazard ratio, 1.01, 95% CI: 0.97-1.05, P = 0.77) nor the specific apoE isoform, as significant predictors of coronary heart disease.
CONCLUSION: Under standard medical treatment of diabetes, including the control of LDL cholesterol levels, the apoE4 isoform was not associated with coronary heart disease among T2DM patients.

Entities:  

Keywords:  Apolipoprotein E isoform; Atherosclerosis; Type 2 diabetes

Year:  2012        PMID: 22442750      PMCID: PMC3310005          DOI: 10.4239/wjd.v3.i3.54

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  41 in total

1.  The apolipoprotein epsilon2 allele and the severity of coronary artery disease in Type 2 diabetic patients.

Authors:  B Kalix; M C Meynet; M C Garin; R W James
Journal:  Diabet Med       Date:  2001-06       Impact factor: 4.359

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort.

Authors:  Dolores Corella; Olga Portolés; Larraitz Arriola; María Dolores Chirlaque; Aurelio Barrricarte; Francesc Francés; José María Huerta; Nerea Larrañaga; Carmen Martínez; Pablo Martinez-Camblor; Esther Molina; Carmen Navarro; Jose R Quirós; Laudina Rodríguez; María José Sánchez; Emilio Ros; Nuria Sala; Carlos A González; Concepción Moreno-Iribas
Journal:  J Nutr Biochem       Date:  2010-08-05       Impact factor: 6.048

Review 4.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

5.  Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20).

Authors:  H Yokoyama; M Matsushima; K Kawai; K Hirao; M Oishi; H Sugimoto; H Takeda; M Minami; M Kobayashi; H Sone
Journal:  Diabet Med       Date:  2011-10       Impact factor: 4.359

6.  Apovarepsilon(4) allele increases the risk for exercise-induced silent myocardial ischemia in non-insulin-dependent diabetes mellitus.

Authors:  X Guangda; X Bangshun; L Xiujian; H Yangzhong
Journal:  Atherosclerosis       Date:  1999-12       Impact factor: 5.162

Review 7.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

8.  Increased frequency of apolipoprotein epsilon 4 allele in type II diabetes with hypercholesterolemia.

Authors:  M Eto; K Watanabe; Y Iwashima; A Morikawa; N Chonan; E Oshima; M Sekiguchi; K Ishii
Journal:  Diabetes       Date:  1987-11       Impact factor: 9.461

9.  Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study.

Authors:  Tomohiro Katsuya; Shunroku Baba; Kazuhiko Ishikawa; Toshifumi Mannami; Yuxiao Fu; Nozomu Inamoto; Takashi Asai; Masayuki Fukuda; Jitsuo Higaki; Jun Ogata; Toshio Ogihara
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  4 in total

1.  Sitagliptin counteracts seasonal fluctuation of glycemic control.

Authors:  Tomohiro Matsuhashi; Motoaki Sano; Keiichi Fukuda; Shun Kohsaka; Yoshihiko Suzuki
Journal:  World J Diabetes       Date:  2012-06-15

2.  Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease.

Authors:  Rong Shi; Birong Wu; Zheyun Niu; Hui Sun; Fan Hu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-18       Impact factor: 3.168

3.  The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes).

Authors:  Annick M McIntosh; Calvin Bennett; Dara Dickson; Stephanie F Anestis; David P Watts; Timothy H Webster; M Babette Fontenot; Brenda J Bradley
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

4.  The long-term coronary heart disease risk of previously obese patients with type 2 diabetes mellitus.

Authors:  Ritsuko Yamamoto-Honda; Hideki Ehara; Hiroji Kitazato; Yoshihiko Takahashi; Shoji Kawazu; Yasuo Akanuma; Mitsuhiko Noda
Journal:  BMC Endocr Disord       Date:  2013-10-03       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.